Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2023-07-31 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
2023年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2023 Fourth Extraordinary General Meeting Resolution Announcement" of Tian Kang Biological Co., Ltd. It details the convening and attendance of the shareholders' meeting, the voting results on specific proposals, and includes legal opinions on the meeting's validity. The content focuses on the announcement of the resolutions passed at the shareholders' meeting rather than the meeting materials or the full report. The document length is about 2068 characters, which is relatively short and consistent with an announcement of voting results rather than a full report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-07-31 Chinese
关于天康生物股份有限公司2023年第四次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and procedures of the 2023 fourth extraordinary general meeting (EGM) of Tian Kang Biological Co., Ltd. It details the legality of the meeting's call, attendance, voting procedures, and results. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting process and resolutions. It is not an announcement of voting results per se, but a legal opinion letter related to the meeting. Given the nature of the document as a legal opinion letter on a shareholder meeting, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-07-31 Chinese
关于控股股东增持公司股份计划时间过半的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a shareholding increase plan by the company's controlling shareholder. It details the number of shares increased, the timeline, the purpose, and compliance with regulations. It does not contain financial statements or detailed financial performance data. The document is a regulatory announcement about shareholding changes, specifically an update on a capital increase plan by a major shareholder. This fits best under the category of Major Shareholding Notification (MRQ). The document length is 2722 characters, which is relatively short and focused on shareholding changes rather than a full report or financial results. Therefore, the classification is MRQ with high confidence.
2023-07-28 Chinese
2023年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2023 semi-annual performance forecast (半年度业绩预告) for the period January 1, 2023 to June 30, 2023. It contains estimated financial results, including expected losses and explanations for performance changes. The document explicitly states it is a forecast and preliminary estimate, not audited, and that the actual financial data will be disclosed in the 2023 semi-annual report. The document length is short (1163 characters) and it is an announcement of expected financial results rather than a full interim report with actual financial statements. Therefore, it fits best as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. H1 2023
2023-07-14 Chinese
关于2023年度为子公司银行融资提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tian Kang Biological Co., Ltd. regarding the provision of guarantees for bank financing to its subsidiaries for the year 2023. It includes details about the guarantee amounts, the subsidiaries involved, their financial conditions, board approval, and risk considerations. The document is a formal public announcement about financing guarantees and does not contain comprehensive financial statements or detailed financial performance data. It is not an annual or interim report, nor is it a call transcript or management report. It is also not a report publication announcement since it contains substantive information about the guarantees. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company for its subsidiaries' bank loans.
2023-07-13 Chinese
公司章程（2023年7月修订）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Tian Kang Biology Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board and management structure, share issuance and transfer, shareholder meetings, and voting procedures. It references Chinese company law, securities law, and regulatory approvals. The content is about the governance framework and operational rules of the company rather than financial results, audit opinions, or meeting announcements. It is not a report of financial performance, nor an announcement or transcript. It is a governance document detailing internal rules and board/shareholder structures. Therefore, the most appropriate classification is Governance Information (CGR). The document length and detail confirm it is not a brief announcement or notice but a substantive governance report.
2023-07-13 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.